President Donald Trump signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations and expanding the scope of a July 2020 action.
A meeting with top pharmaceutical executives that President Donald Trump promised wasn called off, a White House official said.
One of the key takeaways from BIO-Europe Spring 2020, which was held virtually March 23-27, was that there is a keen need for greater collaboration and communications among the biotech community, government, non-governmental organizations and the public.
On the same day the White House tapped Vice President Mike Pence to lead the government response to the coronavirus, the Biotechnology Innovation Organization (BIO) tapped George Scangos to head up its own response to the outbreak, which causes the COVID-19 disease.
In a first-of-its-kind effort, the Biotechnology Innovation Organization (BIO) conducted a survey that attempts to dive into diversity within the pharmaceutical and biotech industry.